Amylyx Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Amylyx Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2022 to Q3 2024.
  • Amylyx Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending September 12, 2024 was $100K.
  • Amylyx Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $2.4M, a 71.4% increase from 2022.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $100K Sep 12, 2024 10-Q 2024-11-07
Q1 2023 $600K +$500K +500% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $100K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.